AC
JNJ icon

Ascend Capital’s Johnson & Johnson JNJ Stock Holding History

Ascend Capital’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-100,252
Closed -$12.8M – 202
2018
Q1 		$12.8M Buy
+100,252
New +$13.6M 0.52% 68
2015
Q4 		– Sell
-609,391
Closed -$56.9M – 164
2015
Q3 		$56.9M Buy
+609,391
New +$58.9M 2.23% 12

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ascend Capital's JNJ Position: Q2 2018 in Review

Ascend Capital sold out of Johnson & Johnson (JNJ) in Q2 2018, closing a stake of 100,252 shares — an estimated $12.8M sold.

Ascend Capital first reported a position in JNJ in Q3 2015 and held it in 2 quarters. The position peaked at $56.9M in Q3 2015. 2,593 funds tracked by Wall St. Rank hold JNJ as of Q2 2018.

  • Ascend Capital reported no remaining Johnson & Johnson position as of Q2 2018 after selling out during the quarter.
  • Ascend Capital sold 100,252 Johnson & Johnson shares in Q2 2018, an estimated $12.8M.
  • Ascend Capital first reported a position in Johnson & Johnson in Q3 2015 and held it in 2 quarters.
  • Ascend Capital's Johnson & Johnson position peaked at $56.9M in Q3 2015.
  • 2,593 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2018.

Based on Ascend Capital's 13F filing for Q2 2018, filed 13 Aug 2018.